Investing
Investment Proceeds
Vertex Pharmaceuticals Investment Proceeds decreased by 17.9% to $1.09B in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 25.2%, from $1.46B to $1.09B. Over 4 years (FY 2021 to FY 2025), Investment Proceeds shows an upward trend with a 85.4% CAGR.
Analysis
StatementCash Flow Statement
SectionInvesting
CategoryLiquidity
SignalContext dependent
VolatilityVolatile
First reportedQ4 2013
Last reportedQ4 2025
How to read this metric
Higher inflows signal a conversion of financial assets back into cash, often used to fund dividends, buybacks, or capital projects.
Detailed definition
The total cash inflow generated from the sale or maturity of marketable securities and other investment instruments. Thi...
Peer comparison
Peer companies with significant 'cash piles' frequently rotate these assets, resulting in large offsetting inflows and outflows.
Metric ID:
cf_proceeds_from_investmentsHistorical Data
19 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $103.20M | $230.86M | $47.17M | $129.70M | $112.60M | $193.60M | $484.10M | $50.00M | $239.80M | $331.20M | $218.10M | $710.50M | $1.18B | $1.11B | $1.46B | $1.64B | $1.84B | $1.33B | $1.09B |
| QoQ Change | — | +123.7% | -79.6% | +175.0% | -13.2% | +71.9% | +150.1% | -89.7% | +379.6% | +38.1% | -34.1% | +225.8% | +66.4% | -5.9% | +31.3% | +12.1% | +12.3% | -27.7% | -17.9% |
| YoY Change | — | — | — | — | +9.1% | -16.1% | +926.4% | -61.4% | +113.0% | +71.1% | -54.9% | >999% | +393.2% | +235.8% | +569.5% | +130.5% | +55.5% | +19.5% | -25.2% |
Range$47.17M – $1.84B
CAGR+68.9%
Avg YoY Growth+245.8%
Median YoY Growth+71.1%
Current Streak2 quarters decline
Investment Proceeds at Other Companies
Frequently Asked Questions
- What is Vertex Pharmaceuticals's investment proceeds?
- Vertex Pharmaceuticals (VRTX) reported investment proceeds of $1.09B in Q4 2025.
- How has Vertex Pharmaceuticals's investment proceeds changed year-over-year?
- Vertex Pharmaceuticals's investment proceeds decreased by 25.2% year-over-year, from $1.46B to $1.09B.
- What is the long-term trend for Vertex Pharmaceuticals's investment proceeds?
- Over 4 years (2021 to 2025), Vertex Pharmaceuticals's investment proceeds has grown at a 85.4% compound annual growth rate (CAGR), from $499.30M to $5.90B.
- What does investment proceeds mean?
- The cash received when a company sells its investments or when those investments reach their end date.